Evidence map›Paper›PMID 40946266›Full record

ArticleClinical journal of gastroenterology2025

A case of pancreatic metastatic tumor of renal cell carcinoma positive for somatostatin receptor scintigraphy.

Akinobu Sai, Hiroaki Yasuda, Hayato Miyake, Yoshio Sogame, Junichi Sakagami, Satoru Yasukawa, Eiichi Konishi, Yuta Inoue, Fumiya Hongo, Yoshito Itoh

Abstract readCase Reports
PubMed Publisher
In one paragraph

Article in Clinical journal of gastroenterology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Akinobu SaiDepartment of Medicine, Division of Molecular Gastroenterology and Hepatology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, 602-8566, Japan.
Hiroaki YasudaDepartment of Medicine, Division of Molecular Gastroenterology and Hepatology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, 602-8566, Japan. hiyasuda@koto.kpu-m.ac.jp.ORCID http://orcid.org/0000-0002-8346-9853
Hayato MiyakeDepartment of Medicine, Division of Molecular Gastroenterology and Hepatology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, 602-8566, Japan.
Yoshio SogameDepartment of Medicine, Division of Molecular Gastroenterology and Hepatology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, 602-8566, Japan.
Junichi SakagamiDepartment of Medicine, Division of Molecular Gastroenterology and Hepatology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, 602-8566, Japan.
Satoru YasukawaDepartment of Surgical Pathology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, 602-8566, Japan.
Eiichi KonishiDepartment of Surgical Pathology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, 602-8566, Japan.
Yuta InoueDepartment of Urology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, 602-8566, Japan.
Fumiya HongoDepartment of Urology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, 602-8566, Japan.
Yoshito ItohDepartment of Medicine, Division of Molecular Gastroenterology and Hepatology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, 602-8566, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pancreatic metastases of renal cell carcinoma, like pancreatic neuroendocrine neoplasms, are hypervascular tumors, so their differentiation is often difficult. In addition, renal cell carcinomas are also often positive for somatostatin receptor scintigraphy, which has been recognized as a diagnostic imaging tool, especially for neuroendocrine neoplasms. We herein report a case of pancreatic metastasis of renal cell carcinoma positive for somatostatin receptor scintigraphy in which the diagnosis was made by EUS-FNA 12 years after the resection of renal cell carcinoma and the expression of somatostatin receptor subtypes in the resected specimens of pancreatic metastasis was examined.

Indexed as

Carcinoma, Renal CellKidney NeoplasmsPancreatic NeoplasmsReceptors, SomatostatinEndoscopic Ultrasound-Guided Fine Needle AspirationHumansMaleMiddle AgedRadionuclide ImagingReceptors, SomatostatinPancreatic metastasisRenal cell carcinomaSomatostatin receptor scintigraphySubtype of somatostatin receptor

Identifiers

PMID40946266

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.